This week in cardiology from heartwire

View all posts »

#177: Runner who died during London Marathon took stimulant DMAA during race; weight-loss myths refuted in new review; new AHA/ASA guidelines for acute stroke treatment; slight risk of QT-interval prolongation found with two antidepressants

Feb 8, 2013 10:25 EST


For the week ending February 8, 2013 we discuss the following top cardiology news from heartwire:

 

And also, in brief:

 

Join us for a comprehensive review of this week's most important cardiology news.





« Previous Post
#178: Short course of aspirin, clopidogrel cuts stroke risk; Lp(a) gene variant associated with aortic stenosis; MAGELLAN published: Rivaroxaban reduces VTE risk in acutely ill patients; weight-loss drug Qsymia improves cardiovascular risk profile
Feb 15, 2013 13:25 EST Next post »
#176: No benefit to dual RAS blockade in meta-analysis; metabolic syndrome in 40s linked to TV, lack of exercise, at age 16; Canadian Riata experience: Electrical failures eclipse externalized cables; "napkin-ring sign" on CT identifies high-risk coronary
Feb 1, 2013 10:45 EST




You must be a member (with full membership) to post a comment.
Already a member?
Enter your login information below:
 Remember me on this computer
Forgot your username and/or password?
        Login        
Enjoy all the benefits of theheart.org

With full membership, you can check out our educational and editorial content, search the site, receive our newsletters, join discussions, download slides and much more.

Membership is free!

    Join now for full access